LEIDEN, Netherlands & CAMBRIDGE, Mass., June 08, 2020 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. (Nasdaq:PRQR), a company dedicated to changing lives through the creation of transformative RNA therapies for severe genetic rare diseases, today announced a virtual presentation of data fro
LEIDEN, Netherlands & CAMBRIDGE, Mass., April 23, 2021 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. (Nasdaq:PRQR), a company dedicated to changing lives through the creation of transformative RNA therapies for
… the Association for Research in Vision and Ophthalmology (ARVO) 2022 LEIDEN, Netherlands & CAMBRIDGE, Mass., April 26, … the Association for Research in Vision and Ophthalmology (ARVO) being held May 1-4, 2022, both in Denver, CO, U.S. …
… Trial and Highlights Ophthalmology Presentations at ARVO Key Updates Enrollment is on track in the ongoing Phase … corneal dystrophy and Stargardt’s disease at the ARVO annual meeting. The company will also deliver a … Fighting Blindness/Casey Innovation summit prior to ARVO. LEIDEN, the Netherlands, April 23, 2018 (GLOBE …
… Data Presentations for QR-110 for LCA10 at the 2016 ARVO Annual Meeting LEIDEN, Netherlands, April 25, 2016 … the Association for Research in Vision and Ophthalmology (ARVO) in Seattle, WA, May 1 – 5, 2016. QR-110 is the second …
ProQR has announced the completion of an in-depth strategic review designed to deliver on our commitment to advance RNA therapies for diseases with high unmet need. We are also sharing additional analyses of the sepofarsen Illuminate trial.
… the Association for Research in Vision and Ophthalmology (ARVO) and the annual meeting of the American Society for … the Association for Research in Vision and Ophthalmology (ARVO) The conference is being held from April 28 – May 2, …
… Retinal Cell and Gene Therapy Innovation Summit and the ARVO 2022 Annual Meeting Corporate strategy to focus on … the Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting, May 1-4, 2022. Operational u pdates The …
